Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for cutting-edge treatment. The CAR T-cell therapy involves the col ...
Zacks Investment Research on MSN6d
Ionis Out-Licenses Rights for Rare Blood Cancer Drug to OnoIonis Pharmaceuticals IONS signed a license agreement with Japan-based Ono Pharmaceutical. Per the terms, Ono has acquired ...
News-Medical.Net on MSN8d
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...
In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...
Jan. 16, 2025 — Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials ... New Innovative Local ...
Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback